§ Mr. Gryllsasked the Secretary of State for Social Services if he will estimate the reduction in the National Health Service drugs bill that will be derived from further reductions in return on capital allowed to pharmaceutical manufacturers under the pharmaceutical price regulation scheme to take effect from 1 April.
§ Mr. Kenneth ClarkeWe estimate that the full year effect from price increases avoided and price reductions secured will be £40—£45 million (United Kingdom).